Detalles de la búsqueda
1.
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study.
Clin Lung Cancer
; 23(8): 720-730, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038416
Resultados
1 -
1
de 1
1
Próxima >
>>